June 17, 2022
Article
Selpercatinib (Retevmo, Loxo Oncology) is FDA-approved to treat 3 types of tumors—metastatic RET fusion-positive non-small cell lung cancer, advanced medullary thyroid cancer (MTC) or MTC that has spread, and advanced RET fusion-positive thyroid cancer.
May 23, 2022
Pharmacists must communicate more than drugs and dosages and offer counseling on lifestyle and sleep habits.